期刊文献+
共找到112篇文章
< 1 2 6 >
每页显示 20 50 100
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
1
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL uses Cosmetic Application
下载PDF
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
2
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
3
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
4
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
5
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL uses PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
6
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
7
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
8
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
贝伐珠单抗联合紫杉醇+卡铂治疗持续性或复发性宫颈癌的临床观察
9
作者 张力忆 蒋奉希 桂定清 《中国药房》 CAS 北大核心 2024年第17期2126-2130,共5页
目的探讨贝伐珠单抗联合紫杉醇(PTX)+卡铂(CBP)化疗方案治疗持续性或复发性宫颈癌的近远期疗效,以及对患者生存质量、肿瘤标志物和安全性的影响。方法采用随机数字表法将我院2020年1月-2022年10月收治的持续性或复发性宫颈癌患者80例分... 目的探讨贝伐珠单抗联合紫杉醇(PTX)+卡铂(CBP)化疗方案治疗持续性或复发性宫颈癌的近远期疗效,以及对患者生存质量、肿瘤标志物和安全性的影响。方法采用随机数字表法将我院2020年1月-2022年10月收治的持续性或复发性宫颈癌患者80例分为对照组(40例)与观察组(40例)。两组患者均接受PTX+CBP化疗,观察组患者同时联用贝伐珠单抗治疗,均连续治疗6个周期。比较两组患者的近期疗效、毒副反应发生情况以及治疗前和全部疗程结束时的欧洲癌症研究与治疗组织生活质量核心问卷量表30(EORTC QLQ-C30)评分、血清肿瘤标志物[癌胚抗原(CEA)、糖类抗原125(CA125)、鳞状细胞癌抗原(SCCA)]水平。采用Kaplan-Meier法绘制两组患者的生存曲线并通过Log-rank检验比较两组患者的无进展生存期(PFS)和总生存期(OS)。结果观察组患者的客观有效率显著高于对照组(62.50%vs.35.00%,P<0.05),中位PFS(9.30个月vs.6.30个月)和中位OS(14.90个月vs.10.60个月)均显著长于对照组(P<0.05),治疗后的EORTC QLQ-C30评分显著高于对照组(P<0.05)。相较于治疗前,两组患者治疗后的血清CEA、CA125和SCCA水平均显著降低(P<0.05),且观察组患者较对照组的降低幅度更大(P<0.05)。两组患者治疗期间各类型毒副反应分级比较,差异无统计学意义(P>0.05);多数患者的毒副反应在停药后1~2个月自动消失或在对症治疗后消失。结论贝伐珠单抗联合PTX+CBP化疗方案可有效提高持续性或复发性宫颈癌患者的客观有效率,降低血清肿瘤标志物水平,提升患者生存质量,延长患者生存期,且安全性良好。 展开更多
关键词 持续性宫颈癌 复发性宫颈癌 贝伐珠单抗 紫杉醇 卡铂 临床疗效 生存质量 肿瘤标志物 安全性
下载PDF
贝伐珠单抗联合紫杉醇和铂类化疗治疗晚期宫颈癌效果
10
作者 郭仁芬 柴芳 +1 位作者 邢孔浪 莫翠婷 《中国计划生育学杂志》 2024年第3期568-572,共5页
目的:研究贝伐珠单抗联合紫杉醇和铂类化疗对晚期宫颈癌患者治疗效果。方法:选取本院2021年4月-2023年8月收治的晚期宫颈癌患者120例,分为观察组(60例)和对照组(60例)。给予放疗后,对照组采用紫杉醇联合铂类药物化疗,观察组在对照组基... 目的:研究贝伐珠单抗联合紫杉醇和铂类化疗对晚期宫颈癌患者治疗效果。方法:选取本院2021年4月-2023年8月收治的晚期宫颈癌患者120例,分为观察组(60例)和对照组(60例)。给予放疗后,对照组采用紫杉醇联合铂类药物化疗,观察组在对照组基础上增加贝伐珠单抗治疗。观察两组疼痛和生存状况、临床疗效、T淋巴细胞亚群、肿瘤标志物及不良反应状况。结果:观察组与对照组治疗后疼痛VAS评分(2.03±0.24分、3.16±0.33分)、血清糖链抗原125(22.24±2.30 U/ml、31.46±3.04 U/ml)、癌胚抗原(2.11±0.22μg/L、3.67±0.30μg/L)、鳞状细胞癌抗原(4.01±0.39μg/L、6.21±0.51μg/L)、CD8+水平均较治疗前降低,卡氏生活质量评分(85.20±8.45分、73.43±7.31分)、CD3^(+)、CD4^(+)水平及有效率(66.7%、40.0%)均较治疗前升高,且观察组变化幅度大于对照组(均P<0.05);两组不良反应(26.7%、20.0%)无差异(P>0.05)。结论:贝伐珠单抗联合紫杉醇和铂类化疗对晚期宫颈癌有良好治疗效果,未增加不良反应发生。 展开更多
关键词 晚期宫颈癌 化疗 铂类 紫杉醇 贝伐珠单抗 糖链抗原125 癌胚抗原 鳞状细胞癌抗原 疗效
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
11
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
白蛋白结合型紫杉醇联合顺铂治疗中晚期宫颈癌的效果分析
12
作者 陈坤燕 顾欣欣 《实用妇科内分泌电子杂志》 2024年第10期27-29,34,共4页
目的探讨晚期宫颈癌采用白蛋白结合型紫杉醇联合顺铂的治疗效果。方法选择98例中晚期宫颈癌患者为研究对象,根据随机数字表法分为研究组和对照组,每组49例。对照组采用紫杉醇结合顺铂治疗,研究组采用白蛋白结合型紫杉醇联合顺铂治疗,比... 目的探讨晚期宫颈癌采用白蛋白结合型紫杉醇联合顺铂的治疗效果。方法选择98例中晚期宫颈癌患者为研究对象,根据随机数字表法分为研究组和对照组,每组49例。对照组采用紫杉醇结合顺铂治疗,研究组采用白蛋白结合型紫杉醇联合顺铂治疗,比较两组血清肿瘤标志物水平、治疗效果及不良反应。结果治疗前,两组鳞状上皮细胞癌抗原(SCCA)、细胞角蛋白19的可溶性片段(CYFRA21-1)水平比较,差异均无统计学意义(P>0.05);治疗后,研究组SCCA、CYFRA21-1水平均低于对照组(P<0.05);研究组治疗总有效率高于对照组(P<0.05);研究组不良反应发生率低于对照组(P<0.05)。结论中晚期宫颈癌采用白蛋白结合型紫杉醇联合顺铂的治疗效果较好,可降低血清肿瘤标志物水平,减少不良反应发生率,值得临床推广与应用。 展开更多
关键词 宫颈癌 中晚期 白蛋白结合型紫杉醇 顺铂 治疗效果
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
13
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
氨磷汀联合紫杉醇、卡铂治疗卵巢癌的临床效果
14
作者 曹云 《妇儿健康导刊》 2023年第13期120-122,共3页
目的探讨氨磷汀联合紫杉醇、卡铂治疗卵巢癌的临床效果。方法选取2020年1月至2022年11月山西省肿瘤医院收治的156例卵巢癌患者,按照不同治疗方法分为对比组和联合组,每组各78例。对比组采用紫杉醇+卡铂化疗方案,联合组在对比组基础上联... 目的探讨氨磷汀联合紫杉醇、卡铂治疗卵巢癌的临床效果。方法选取2020年1月至2022年11月山西省肿瘤医院收治的156例卵巢癌患者,按照不同治疗方法分为对比组和联合组,每组各78例。对比组采用紫杉醇+卡铂化疗方案,联合组在对比组基础上联合氨磷汀。比较两组治疗效果、肿瘤标志物水平、不良反应发生情况。结果联合组治疗总有效率高于对比组(P<0.05)。治疗后,联合组肿瘤标志物水平均低于对比组(P<0.05)。联合组骨髓抑制、周围神经毒性反应发生率低于对比组(P<0.05)。结论氨磷汀联合紫杉醇、卡铂治疗卵巢癌可提高临床效果,有利于控制肿瘤进展并降低肿瘤标志物水平,有效避免骨髓抑制、周围神经毒性反应的发生。 展开更多
关键词 氨磷汀 紫杉醇 卡铂 卵巢癌 治疗效果
下载PDF
The role of drug utilization evaluation in medical sciences
15
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 Anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
16
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
含顺铂与不含顺铂方案治疗晚期食管癌的临床分析 被引量:6
17
作者 蔡锐刚 黄镜 +1 位作者 吕纪马 孙燕 《中华肿瘤防治杂志》 CAS 2008年第23期1818-1820,共3页
目的:探讨晚期食管癌的化疗疗效及预后。方法:对行化疗的83例晚期食管癌患者临床资料进行回顾性分析。化疗按含顺铂(59例)及不含顺铂(24例)方案分两组。结果:化疗的总有效率为30.0%。化疗后中位生存期为7个月,1、2年生存率分别为37.3%和... 目的:探讨晚期食管癌的化疗疗效及预后。方法:对行化疗的83例晚期食管癌患者临床资料进行回顾性分析。化疗按含顺铂(59例)及不含顺铂(24例)方案分两组。结果:化疗的总有效率为30.0%。化疗后中位生存期为7个月,1、2年生存率分别为37.3%和7.7%。含顺铂方案的有效率为37.3%,高于不含顺铂方案的12.5%,差异有统计学意义,χ2=4.98,P=0.026。化疗有效患者的中位生存期为13个月,明显长于化疗无效患者的6个月,差异有统计学意义,Logrank值为7.59,P=0.0059。结论:食管癌化疗应首选含顺铂的方案,初次化疗有效能明显延长患者的生存期。 展开更多
关键词 食管肿瘤/药物疗法 顺铂/治疗应用 紫杉酚/治疗应用
下载PDF
多西紫杉醇加铂类两周方案治疗晚期非小细胞肺癌的疗效和生活质量评价 被引量:6
18
作者 吴海鹰 戴文清 +3 位作者 刘俊玲 段海波 黄蕾 史艳侠 《中华肿瘤防治杂志》 CAS 2006年第17期1325-1328,共4页
目的:研究多西紫杉醇加铂类药物2周给药一线治疗晚期非小细胞肺癌(non-smallcelllungcancer,NSCLC)的疗效、毒副反应及生活质量评价。方法:多西紫杉醇75mg/m2静脉滴入,加用卡铂300mg/m2静脉滴入或顺铂25mg/(m2·d)×3d静脉滴入... 目的:研究多西紫杉醇加铂类药物2周给药一线治疗晚期非小细胞肺癌(non-smallcelllungcancer,NSCLC)的疗效、毒副反应及生活质量评价。方法:多西紫杉醇75mg/m2静脉滴入,加用卡铂300mg/m2静脉滴入或顺铂25mg/(m2·d)×3d静脉滴入联合化疗,每2周重复疗程。化疗期间用G-CSF预防性支持治疗。采用EORTCQLQ-C30和QLQ-LC13量表评价患者生活质量。化疗前、下个疗程的前1d及化疗结束后给予评价患者生活质量。结果:47例初治的晚期NSCLC接受化疗,42例患者可评价疗效,其中1例(2·4%)CR,16例(38·1%)PR,24例(57·1%)SD,1例(2·4%)PD。总有效率RR为40·5%。多西紫杉醇加顺铂组28例,RR35·7%,SD60·7%,PD3·6%;多西紫杉醇加卡铂组14例,RR50·0%,SD50·0%。两组有效率比较差异无统计学意义,P=0·374。毒副反应主要为骨髓抑制、恶心呕吐、脱发、肌肉关节痛及疲劳等。化疗后患者躯体功能较化疗前提高,咳嗽、气促、咯血及肩痛等症状明显缓解,整体生活质量并未因化疗而下降。客观疗效稳定的患者与有效患者生活质量改善相似。结论:多西紫杉醇加铂类药物每2周给药是治疗晚期NSCLC的有效可行的方案,毒性反应患者可耐受,大部分患者在化疗后可获得明显的症状和生活质量的改善。 展开更多
关键词 非小细胞肺/药物疗法 紫杉酚/治疗应用 顺铂/治疗应用 卡铂/治疗应用 药物疗法 联合 生活质量
下载PDF
胃癌术后2种辅助化疗方案的疗效及安全性分析 被引量:6
19
作者 李晓芬 崔学芳 +1 位作者 李晶晶 袁瑛 《实用肿瘤杂志》 CAS 2013年第3期309-311,共3页
目的比较奥沙利铂联合5-FU或紫杉醇联合5-FU 2种化疗方案对胃癌根治术后患者的临床疗效和不良反应。方法 51例胃癌根治术后患者,37例接受奥沙利铂联合5-FU方案化疗(奥沙利铂组),14例接受紫杉醇联合5-FU方案化疗(紫杉醇组),随访2年。结果... 目的比较奥沙利铂联合5-FU或紫杉醇联合5-FU 2种化疗方案对胃癌根治术后患者的临床疗效和不良反应。方法 51例胃癌根治术后患者,37例接受奥沙利铂联合5-FU方案化疗(奥沙利铂组),14例接受紫杉醇联合5-FU方案化疗(紫杉醇组),随访2年。结果 47例患者有完整的随访资料。奥沙利铂组和紫杉醇组的1年无瘤生存率分别为72.7%和64.3%,2年无瘤生存率分别为72.7%和57.1%;1年生存率分别为87.9%和78.6%,2年生存率分别为78.8%和57.1%。奥沙利铂组的无瘤生存率、总生存率略高于紫杉醇组,但两者之间差异无统计学意义(P>0.05)。单因素分析显示男性患者的2年无瘤生存率和2年总生存率均显著高于女性患者(P<0.05)。2组患者不良反应均可耐受;奥沙利铂组Ⅲ~Ⅳ度恶心、呕吐、中性粒细胞减少、周围神经毒性发生率多于紫杉醇组,差异无统计学意义(P>0.05)。结论奥沙利铂联合5-FU或紫杉醇联合5-FU两种化疗方案是胃癌根治术后有效的辅助化疗方案,且不良反应可耐受,安全性高。 展开更多
关键词 胃肿瘤 药物疗法 化学疗法 辅助 奥沙利铂 治疗应用 紫杉酚 治疗应用 回顾性研究
下载PDF
六君子汤加减辅助晚期非小细胞肺癌化疗的临床观察 被引量:21
20
作者 李德辉 孙春霞 范焕芳 《中国药房》 CAS 北大核心 2017年第36期5068-5071,共4页
目的:观察六君子汤加减辅助晚期非小细胞肺癌化疗的疗效和安全性。方法:118例晚期非小细胞肺癌患者随机分为观察组(59例)和对照组(59例)。两组患者于化疗前12、6 h给予醋酸地塞米松片15 mg,口服,化疗前30 min给予盐酸苯海拉明注射液20 ... 目的:观察六君子汤加减辅助晚期非小细胞肺癌化疗的疗效和安全性。方法:118例晚期非小细胞肺癌患者随机分为观察组(59例)和对照组(59例)。两组患者于化疗前12、6 h给予醋酸地塞米松片15 mg,口服,化疗前30 min给予盐酸苯海拉明注射液20 mg,肌内注射,同时行常规抑酸、保肝、止吐、水化、利尿等治疗。在此基础上,对照组患者给予紫杉醇注射液175 mg/m^2,静脉滴注,3 h内滴完,d_1,30 min后给予注射用顺铂25 mg/m^2,静脉滴注2 h,d_(1-3);观察组患者在对照组治疗的基础上给予六君子汤加减,水煎至200 mL,每日1剂,早晚分服。两组均以21 d为1个周期,共治疗4个周期。观察两组患者的近期疗效,化疗前后T淋巴细胞亚群水平、肿瘤标志物水平[癌胚抗原(CEA)、鳞状上皮细胞癌抗原(SCC-Ag)和细胞角蛋白19的可溶性片段(CYFRS21-1)]及毒副反应发生情况。结果:观察组患者近期总有效率(49.15%)显著高于对照组(32.20%),血小板降低、白细胞降低、肝功能异常、消化道反应、外周神经损伤发生率均显著低于对照组,差异均有统计学意义(P<0.05)。化疗后,观察组患者CD4^+、CD4^+/CD8^+均显著高于同组化疗前,CD8^+显著低于同组化疗前,对照组患者CD4^+、CD4^+/CD8^+均显著低于同组化疗前,CD8^+显著高于同组化疗前,且观察组CD4^+、CD4^+/CD8^+显著高于对照组,CD8^+显著低于对照组;两组患者肿瘤标志物水平均显著低于同组化疗前,且观察组显著低于对照组,差异均有统计学意义(P<0.05)。结论:在常规治疗的基础上,六君子汤加减用于晚期非小细胞肺癌的疗效显著,可改善患者免疫功能,减轻毒副反应。 展开更多
关键词 非小细胞肺癌 紫杉醇 顺铂 六君子汤 疗效 安全性
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部